154 related articles for article (PubMed ID: 14982154)
1. Lipomic profiling in drug discovery, development and clinical trial evaluation.
Watkins SM
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):112-7. PubMed ID: 14982154
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics and biochemical profiling in drug discovery and development.
Watkins SM; German JB
Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307
[TBL] [Abstract][Full Text] [Related]
3. Advances in high-throughput mass spectrometry.
Morand KL; Burt TM; Regg BT; Tirey DA
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):729-35. PubMed ID: 11899612
[TBL] [Abstract][Full Text] [Related]
4. The emerging field of lipidomics.
Wenk MR
Nat Rev Drug Discov; 2005 Jul; 4(7):594-610. PubMed ID: 16052242
[TBL] [Abstract][Full Text] [Related]
5. Analytical strategies in lipidomics and applications in disease biomarker discovery.
Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
[TBL] [Abstract][Full Text] [Related]
6. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
Castro-Perez JM
Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
[TBL] [Abstract][Full Text] [Related]
7. Putting the 'Ome' in lipid metabolism.
Mutch DM; Fauconnot L; Grigorov M; Fay LB
Biotechnol Annu Rev; 2006; 12():67-84. PubMed ID: 17045192
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma.
Dear GJ; Roberts AD; Beaumont C; North SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):182-90. PubMed ID: 19010088
[TBL] [Abstract][Full Text] [Related]
9. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
[TBL] [Abstract][Full Text] [Related]
10. Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids - a methodological review.
Schiller J; Arnold K
Med Sci Monit; 2002 Nov; 8(11):MT205-22. PubMed ID: 12444388
[TBL] [Abstract][Full Text] [Related]
11. Focused metabolomic profiling in the drug development process: advances from lipid profiling.
Morris M; Watkins SM
Curr Opin Chem Biol; 2005 Aug; 9(4):407-12. PubMed ID: 15979378
[TBL] [Abstract][Full Text] [Related]
12. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
13. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
Nassar AE; Talaat RE; Kamel AM
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
[TBL] [Abstract][Full Text] [Related]
14. A matter of fat: an introduction to lipidomic profiling methods.
Roberts LD; McCombie G; Titman CM; Griffin JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):174-81. PubMed ID: 18458005
[TBL] [Abstract][Full Text] [Related]
15. An update on lipidomics: progress and application in biomarker and drug development.
Han X
Curr Opin Mol Ther; 2007 Dec; 9(6):586-91. PubMed ID: 18041669
[TBL] [Abstract][Full Text] [Related]
16. Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems.
Shibamoto T
J Pharm Biomed Anal; 2006 Apr; 41(1):12-25. PubMed ID: 16497470
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
Schlotterbeck G; Ross A; Dieterle F; Senn H
Pharmacogenomics; 2006 Oct; 7(7):1055-75. PubMed ID: 17054416
[TBL] [Abstract][Full Text] [Related]
18. Lipid species profiling: a high-throughput approach to identify lipid compositional changes and determine the function of genes involved in lipid metabolism and signaling.
Welti R; Wang X
Curr Opin Plant Biol; 2004 Jun; 7(3):337-44. PubMed ID: 15134756
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Tolonen A; Turpeinen M; Pelkonen O
Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
[TBL] [Abstract][Full Text] [Related]
20. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
